Published in PLoS One on May 12, 2016
Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability. Respir Med Case Rep (2017) 0.75
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol (1998) 5.47
Tuberous sclerosis. Lancet (2008) 4.24
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Lymphangioleiomyomatosis: a clinical update. Chest (2008) 3.79
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 3.49
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Causes of death in patients with tuberous sclerosis. Mayo Clin Proc (1991) 3.18
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med (2011) 2.67
Pulmonary lymphangiomyomatosis. A review. Am J Pathol (1975) 2.46
High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc (2000) 2.33
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med (2001) 2.31
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 2.22
Diagnosis of tuberous sclerosis complex. J Child Neurol (2004) 2.11
Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences. Ann Intern Med (2011) 1.92
Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest (2012) 1.87
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69
Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis. Lymphat Res Biol (2006) 1.67
Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis. Chest (2009) 1.64
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet (2002) 1.57
Update on the Diagnosis and Management of Renal Angiomyolipoma. J Urol (2015) 1.52
The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med (2001) 1.35
Pulmonary tuberous sclerosis. Chest (1995) 1.32
Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med (2001) 1.31
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest (2009) 1.28
Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics (2011) 1.27
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol (2010) 1.27
Multifocal micronodular pneumocyte hyperplasia: computed tomographic appearance and follow-up in tuberous sclerosis complex. J Comput Assist Tomogr (2012) 1.27
Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest (2013) 1.05
Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2. Pathol Int (2001) 1.04
Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet (2000) 1.02
Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex. Clin Radiol (2011) 0.99
TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. J Med Genet (2009) 0.95
Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. Respir Res (2012) 0.92
The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM). Respir Med (2012) 0.92
Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients. Eur J Radiol (2014) 0.90
Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study. Eur Respir J (2015) 0.87
Management of lymphangioleiomyomatosis. F1000Prime Rep (2014) 0.79
Severity and outcome of cystic lung disease in women with tuberous sclerosis complex. Eur Respir J (2014) 0.78
Tuberous sclerosis and the lungs. Br Med J (1971) 0.76
Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir Med (2012) 0.76